Default Pathway of Apoptosis in Acute Renal Failure
Default Pathway of Apoptosis in Acute Renal Failure
批准号:
8110544
负责人:
VIMAL PATEL
金额:
$14.2万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2013-06-30
关键词:
Acute Kidney FailureApoptosisApoptosis PromoterAwardBiologyCell DeathCellsChicagoDevelopment PlansDown-RegulationEventFactor AnalysisGenesGoalsGrowth FactorIllinoisIn VitroInterventionKidneyKidney DiseasesMAPK3 geneMapsMediatingMediator of activation proteinMentored Research Scientist Development AwardModelingMolecular BiologyMusPathogenesisPathway interactionsPhaseProximal Kidney TubulesRecoveryRelative (related person)ResearchRodentRoleScientistSignal PathwaySignal TransductionStimulusTechnologyTherapeuticTrainingTreatment EfficacyTubular formationUniversitiesbody systemcareercareer developmentcell injurycytotoxicimprovedin vivoinstructortooltranscription factor
中文摘要
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant):
The overall objective of this research career award application is to understand the role of the default pathway of apoptosis in the pathogenesis of acute renal failure (ARF). The goal of this application is to provide additional training in the rodent acute renal failure model and molecular biology technology to facilitate the candidates transition to an independent scientist in the field of apoptotis research relating to kidney disease. Previous studies on the role of apoptosis in ARF have focused on cytotoxic stimuli as inducers of apoptosis. We suggest that apoptosis of renal tubular cells is due not only to direct cellular injury but also to a relative deficiency of survival factors. Moreover, we suggest that the therapeutic efficacy of growth factors in experimental ARF is mediated, in part, through suppression of cell death and the default pathway of apoptosis. We aim to approach these questions in two ways. An in vitro approach will elucidate the signaling pathways and/or intracellular mediators by which spontaneous activation of ERK1/2 in Mouse Kidney Proximal Tubule (MKPT) cells deprived of all soluble survival factors induces down-regulation of Akt and promotes MKPT cell apoptosis. Through the use of cell signaling and molcular biology tools, we will dissect the mechanism of this relationship and with the use of gene array and transcription factor analysis we will map the downstream events occurring during the default pathway of apoptosis. The in vivo approach will examine the role of the ERK1/2 pathway in recovery from experimental ischemic ARF agin using molcular approaches. Interventions that ameliorate apoptosis during the recovery phase of ARF have great therapeutic potential, since they can be administered after the onset of ARF without the need to anticipate when ARF will occur. The candidate, Vimal Patel, is an Instructor at the University of Illinois, Chicago and the training team of Jerrold Levine, David Ucker, Jose Arruda, David Basile, Wil Leiberthal, Mike Abecassis and John Schwartz consists of established experts in the apoptosis and acute renal failure fields. There is institutional commitment and a integrated career development plan encompasing a broad range of activities. Taken together these studies will improve our understanding of the default pathway in ARF and provide Dr. Patel the rigorous training needed to facilitate his goal of an independent research career. Moreover, these studies should also help in understanding the default pathway of apoptosis in other cell and organ systems.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Default Pathway of Apoptosis in Acute Renal Failure
-
批准号:7260248
-
项目类别:
-
资助金额:$13.52万
-
财政年份:2007
-
负责人:VIMAL PATEL
-
依托单位:
Default Pathway of Apoptosis in Acute Renal Failure
-
批准号:7454218
-
项目类别:
-
资助金额:$13.71万
-
财政年份:2007
-
负责人:VIMAL PATEL
-
依托单位:
Default Pathway of Apoptosis in Acute Renal Failure
-
批准号:7647422
-
项目类别:
-
资助金额:$13.83万
-
财政年份:2007
-
负责人:VIMAL PATEL
-
依托单位:
Default Pathway of Apoptosis in Acute Renal Failure
-
批准号:7878012
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2007
-
负责人:VIMAL PATEL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: